Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis

Affiliations

• ¹ From the Department of Pediatrics (Neurology) (E.A.Y.), SickKids Research Institute, Division of Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto; Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Department of Neurology with Institute of Translational Neurology (H.W.), University of Muenster, Germany. ann.yeh@sickkids.ca.
• ² From the Department of Pediatrics (Neurology) (E.A.Y.), SickKids Research Institute, Division of Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto; Department of Neurology (D.B.), Oregon Health & Science University, Portland; and Department of Neurology with Institute of Translational Neurology (H.W.), University of Muenster, Germany.